Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Prev Med. 2023 Feb 20;169:107458. doi: 10.1016/j.ypmed.2023.107458

Youth and adult understanding of public displays of information about harmful constituents in cigarette smoke

Samantha J Venrick a,*, Katherine A Margolis a, Jennifer K Bernat a, Jessica K Pepper b, James M Nonnemaker b, Matthew E Eggers b
PMCID: PMC10023421  NIHMSID: NIHMS1877619  PMID: 36813248

Abstract

The U.S. FDA is required by law to publicly display a list of harmful and potentially harmful constituents (HPHCs) “by brand and by quantity in each brand and subbrand” in a format that is “understandable and not misleading to a lay person.” An online experiment examined youth and adult understanding of which HPHCs are present in cigarette smoke, understanding of health effects of smoking cigarettes, and endorsement of misleading information after viewing HPHC information displayed in one of six formats. We recruited youth (N = 1324) and adults (N = 2904) from an online panel and randomized them to one of six formats of presenting HPHC information. Participants responded to survey items before and after exposure to an HPHC format. Understanding of HPHCs in cigarette smoke and understanding of health effects of cigarette smoking significantly increased pre- to post-exposure for all formats. Respondents (20.6% to 73.5%) endorsed misleading beliefs after exposure to information about HPHCs. Endorsement of the one misleading belief that was measured pre- and post-exposure significantly increased for viewers of four formats. All formats increased understanding of HPHCs in cigarette smoke and the health effects of smoking cigarettes, but some participants endorsed each misleading belief after exposure to HPHC information.

Keywords: Harmful and potentially harmful constituents, Understanding, Misleadingness, Cigarettes


Tobacco products and tobacco smoke contain thousands of harmful or potentially harmful constituents (HPHCs), many of which are linked to morbidity and mortality (Talhout et al., 2011; U.S. Department of Health and Human Services, 2010). For example, tobacco products and tobacco smoke contain HPHCs that cause addiction (e.g., nicotine), cancer (e.g., formaldehyde), fetal development and sexual problems (e. g., toluene), heart attack and stroke (e.g., benzene), and permanent breathing problems (e.g., ammonia) (Food and Drug Administration, n. d.). The Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) requires the U.S. Food and Drug Administration (FDA) to publicly display a list of HPHCs in tobacco products and tobacco smoke by brand, and by quantity in each brand and subbrand, in a format that is understandable and not misleading to a layperson (Food and Drug Administration, 2015). The statute does not specify the format or location for display of the HPHC information. Awareness of HPHCs is associated with potentially beneficial outcomes such as discouragement from wanting to try or use tobacco products (Brewer et al., 2016; Wiseman et al., 2016; Jeong et al., 2020), quit intentions (Lazard et al., 2020), and quit attempts (Morgan et al., 2017). However, communicating about HPHCs is challenging due to the public’s lack of understanding about HPHCs (Brewer et al., 2016; Wiseman et al., 2016; Jeong et al., 2020; Morgan et al., 2017; Hall et al., 2014; Moracco et al., 2016; Boynton et al., 2016) and misbeliefs about HPHCs (Brewer et al., 2016; Jeong et al., 2020; Morgan et al., 2017; Hall et al., 2014; Moracco et al., 2016; Pepper et al., 2017a). For example, in general, survey respondents frequently misbelieve that HPHCs mostly originate in additives introduced during cigarette manufacturing rather than naturally occurring in tobacco or created by combustion (Brewer et al., 2016; Jeong et al., 2020; Morgan et al., 2017; Hall et al., 2014; Moracco et al., 2016). Most people tested also incorrectly believe that the amount of an HPHC always correlates with its level of harm (Morgan et al., 2017) (i.e., that tobacco brands with fewer HPHCs, lower levels of an HPHC, or labeled “additive-free” are less harmful) (Wiseman et al., 2016). These misbeliefs are problematic because some adolescent and young adult focus group participants have also indicated that they may switch to brands that have lower concentrations of certain HPHCs (Wiseman et al., 2016), which could lead to a lower likelihood of quitting (Tindle et al., 2009).

Recognizing these communication challenges, researchers have examined whether variations in HPHC information content and format influence participants’ understanding and endorsement of misleading beliefs. For example, Lazard et al. examined adult and adolescents’ responses to webpages displaying cigarette HPHC information (Lazard et al., 2020). Participants who viewed a display with health effects listed first and HPHCs listed underneath had greater understanding of HPHCs than participants who viewed a display with HPHCs grouped by their associated health effects, but layout did not otherwise affect understanding and misleadingness (Lazard et al., 2020). Pepper et al. examined adult cigarette users’ responses to stimuli that varied in content and format displaying HPHCs in a smoked cigarette (Pepper et al., 2017b). Including common uses of each HPHC, describing health harms of each HPHC in clinical language, describing health harms of each HPHC in plain language, and graphic vs. non-graphic format affected understanding and misleadingness. In some cases, the formats that were most understandable were also the most misleading (i.e., viewers were more likely to believe that the amount of an HPHC indicates the chance of experiencing harm) (Pepper et al., 2017b). Byron et al. examined cigarette users’ and nonusers’ responses to webpages that presented chemical and health effect information about HPHCs in cigarette smoke (Byron et al., 2018). Participants’ understanding of HPHCs was greatest when webpages presented both familiar and unfamiliar HPHCs and their understanding of health effects was greatest when health effects were presented as text only (Byron et al., 2018). However, variations in content and format did not affect misleadingness (Byron et al., 2018). The results of these studies suggest there is no consensus about the best format for displaying HPHC information or what information to include to maximize understanding and minimize misleadingness.

Given the need to effectively communicate about HPHCs and tobacco-related harms, FDA conducted an experiment to gain further insight into adult and youth comprehension of information about HPHCs in cigarette smoke. We tested six formats that provided HPHC information and examined whether participants’ understanding of HPHCs in cigarette smoke and understanding of the health effects of cigarette smoking changed after exposure to information about HPHCs. We also examined whether, after viewing HPHC information, participants endorsed beliefs indicating that they were misled by the formats. Unlike previous research, this study tests multiple HPHC information formats for a hypothetical cigarette brand to examine which format, if any, has the potential to meet the Tobacco Control Act requirement that HPHC information be presented in a way that is understandable and not misleading to a lay person.

1. Methods

1.1. Participants and procedure

From October 7, 2020 to January 18, 2021, we conducted an online experiment with youth aged 13–17 (N = 1324) who currently used smokeless tobacco (i.e., used smokeless tobacco on at least one of the past 30 days), currently smoked cigarettes (i.e., smoked cigarettes on at least one of the past 30 days), or were not a cigarette user but were susceptible to smoking cigarettes, and adults (N = 2904) who currently used smokeless tobacco, currently smoked cigarettes, or did not use smokeless tobacco or cigarettes. We recruited smokeless tobacco users and non-cigarette users because of concerns that users of potentially less risky products or tobacco nonusers may have decreased perceptions about the harms of smoking after viewing cigarette HPHC information. We recruited cigarette users because they are the target audience for cigarette HPHC information.

Adult participants were recruited via email and completed an online consent form and study screener. Eligible adult participants who completed the study survey received an incentive via the online panel. Youth were recruited via emails to adult panelists whose profiles indicated they were the parent or guardian of a child aged 13–17. Parents provided affirmative permission and youth provided affirmative assent to participate in the study. The online market research vendor compensated parents of youth regardless of youth survey eligibility or survey completion. Quotas were used to ensure participants included various age and tobacco use groups and inclusion of hard-to-reach populations.

After responding to pre-exposure questions on understanding of HPHCs in cigarette smoke and understanding of the health effects of smoking, we randomized participants using simple random assignment to view HPHC information about cigarette smoke displayed in one of six formats. After viewing the format for a minimum of 30 s, participants immediately responded to post-exposure questions. The format stayed visible during question completion, and participants could refer to it when answering the questions. At the end of the study, participants were debriefed. All materials and procedures for this study were approved by the Institutional Review Boards at FDA (Study #18–038CTP) and RTI (IRB ID: STUDY00021430).

1.2. Formats

In prior research conducted by FDA, we found significant gaps in consumer understanding of HPHCs and their health effects. We then conducted 50 interviews to gain a better understanding of how to convey HPHC information to a layperson. We designed six formats for displaying HPHC information based on previous research, including formats developed as part of Center for Tobacco Product, FDA funded administrative supplements to the National Institutes of Health Tobacco Centers of Regulatory Science, published scientific literature, graphic design principles, and health communication principles. All formats listed information about 18 HPHCs present in a fictitious cigarette brand, Durham Cigarettes. The 18 HPHCs are from the Abbbreviated List of Harmful and Potentially Harmful Constituents provided in draft guidance for industry. All formats included information about health effects associated with HPHCs as previous research has found this led to greater knowledge of those health effects (Byron et al., 2018), higher message effectiveness ratings (Noar et al., 2018), and increased potential influence of HPHC information (Lazard et al., 2019). Several of the formats employed graphical elements, such as icons, to increase understanding (Houts et al., 2006; Lazard et al., 2017). However, the formats varied in the type and amount of information included and in the graphical display of that information (See supplemental material for images of all six formats). The study was not designed to compare formats but rather to examine how well each format conveyed HPHC information in a manner that was understandable and not misleading. Supplemental Table 1 provides an overview of the content and visual display of the formats.

1.3. Measures

1.3.1. Demographic information

We collected information on age, sex, race/ethnicity, and, among adults 18 and older, household income, and educational attainment.

1.3.2. Tobacco use

For youth aged 13–17, current cigarette use was defined as having smoked on one or more of the past 30 days. Current smokeless tobacco use was defined as having used smokeless tobacco on one or more of the past 30 days. Youth who had never smoked a cigarette or had not smoked in the past 30 days were only eligible to participate if they were susceptible to smoking (Nicksic and Barnes, 2019). Susceptibility to cigarette smoking was defined as not having smoked cigarettes in the past 30 days and reporting either (1) being “a little,” “somewhat,” or “very” curious about cigarettes; (2) responding “definitely yes,” probably yes,” or “probably not” to the question “Do you think you will smoke a cigarette at any time in the next year?”; or (3) responding “definitely yes,” probably yes,” or “probably not” to the question “If one of your best friends offered you a cigarette, would you smoke it?”

For adults aged 18 and older, current cigarette use was defined as having smoked on one or more of the past 30 days and having smoked 100 or more cigarettes in lifetime. Current smokeless tobacco use was defined as having used smokeless tobacco on one or more of the past 30 days. Non-users of cigarettes and smokeless tobacco were defined as having not used smokeless tobacco in the past 30 days and is not a current cigarette user (i.e., never smoked, has not smoked in the past 30 days, or has not smoked a minimum of 100 cigarettes in lifetime)

We also assessed participants’ past 30-day use of other tobacco products, including electronic nicotine products; cigars, cigarillos, or filtered cigars; tobacco pipe; or waterpipe and hookah.

1.3.3. Understanding of HPHCs in cigarette smoke

Participants responded to five items before and after format exposure to assess understanding of HPHCs in cigarette smoke (e.g., “Does cigarette smoke contain ammonia?”) (Byron et al., 2018). All HPHCs listed in these items were included in all six of the HPHC formats. Responses were coded as correct (“Yes”) or incorrect (“No” or “Don’t Know”) and correct responses were summed, resulting in a 0–5 scale.

1.3.4. Understanding of the health effects of smoking

Participants responded to seven items before and after format exposure to assess understanding of the health effects of smoking (e.g., “Does smoking cause heart attacks?”) (Byron et al., 2018). Responses were coded as correct (“Yes”) or incorrect (“No” or “Don’t Know”) and correct responses were summed, resulting in a 0–7 scale.

1.3.5. Misleadingness

Participants responded to one misleadingness item pre- and post-exposure: “If you learned that your cigarettes have a lot more of a dangerous chemical than other cigarettes, how likely, if at all, would you be to switch brands?” Participants who responded “Extremely likely” or “Likely” were considered misled.

Participants responded to 14 misleadingness items post-exposure only (Byron et al., 2018). Participants were considered misled on the belief if they responded “Strongly Agree” or “Agree” to the belief item. Three of the 14 items were asked only of current cigarette users.

Five items assessed beliefs that HPHC quantity substantially affects risk (e.g., “A cigarette is much safer to smoke if it has less arsenic than other cigarettes”).

Two items addressed beliefs that brands vary in risk (e.g., “Some cigarette brands are much more harmful to smoke than others”).

Like Byron et al., we asked two items only of current cigarette users to assess whether they made comparisons between cigarette brands with incomplete data (e.g., “My brand of cigarettes is probably safer than Durham”).

Five items assessed whether participants perceived that smoking is less dangerous after viewing the HPHC information. One item was asked of current cigarette users only (i.e., “Reading this information about cigarettes makes me less likely to quit smoking”). The other four items were asked of all participants (e.g., “It’s safer to smoke Durham cigarettes than most other cigarettes”). Participants were considered misled if they responded, “Strongly Agree” or “Agree.” Participants were also considered misled if they responded, “Not at all harmful” or “A little harmful” to the item “How harmful are Durham cigarettes (the cigarettes described)?”

1.4. Analysis

Based on a pre-specified statistical analysis plan, we examined sociodemographic and tobacco use characteristics using descriptive statistics. We initially did not compare outcomes based on tobacco use status or age because an HPHC list must be publicly displayed to meet the regulatory requirement and may therefore be viewed by all members of the public, regardless of their tobacco use status or age. All members of the public must therefore understand and not be misled by HPHC information. However, after reviewer feedback we conducted ad-hoc analyses presenting separate results for youth and adults. In supplemental tables 3, 5, and 6, we provide results further separated by tobacco use status. To assess whether understanding increased pre- to post- exposure, we conducted paired t-tests within each study condition. To assess whether participants endorsed misleading beliefs after exposure to HPHC information, we calculated the proportion of participants misled for each of the misleadingness items across the six formats. For the one misleadingness item assessed pre- and post-exposure, we conducted McNemar tests of paired proportions to determine whether responses differed pre- and post-exposure. One observation was excluded from analysis of understanding of HPHCs in cigarette smoke due to missingness. No other observations were excluded from the results reported here due to missingness.

2. Results

2.1. Sample characteristics

Table 1 reports sociodemographic and tobacco use characteristics among participants. Only sex and household income differed significantly across the six study conditions.

Table 1.

Participant Sociodemographic and Tobacco Use Characteristics by Age Group (N = 4228).

Characteristic Adult (n = 2904; 68.7%) % Youth (n = 1324; 31.3%) %
Sex *
 Male 1356 32.1 821 19.4
 Female 1537 36.4 496 11.7
 Other 8 0.2 3 0.1
 Do not wish to answer 3 0.1 4 0.1
Race/ethnicity
 White, non-Hispanic 2155 51.0 1085 25.7
 Black or African American, non-Hispanic 554 13.1 148 3.5
 American Indian or Alaska native 119 2.8 22 0.5
 Asian, non-Hispanic 96 2.3 85 2.0
 Native Hawaiian/other Pacific islander 24 0.6 0.2 0.7
 Hispanic 408 9.9 210 5.1
 Prefer not to answer 25 0.6 19 0.4
Educational attainment
 Less than high school graduate or GED 139 4.9
 High school graduate or GED 527 18.1
 Some college or technical training school 918 31.6
 College graduate 961 33.1
 Postgraduate education 359 12.4
Household income *
 Less than $25,000 504 17.4
 $25,000 to $49,999 746 25.7
 $50,000 to $74,999 787 27.1
 $75,000 or more 867 29.9
Tobacco and nicotine use
 Current cigarette user 2385 56.4 545 12.9
 Susceptible to cigarette smoking 778 58.8
 Current user of smokeless tobacco 1677 39.7 492 11.6
 Current non-user of cigarettes and smokeless tobacco 500 11.8
 Current user of electronic nicotine products 1191 28.2 547 12.9
 Current user of traditional cigars, cigarillos, or filtered cigars 1347 31.9 423 10.0
 Current user of tobacco pipe 840 19.9 239 5.7
 Current user of waterpipe/hookah 838 19.8 274 6.5
 Current non-user of tobacco products 444 10.5
*

Statistically significant difference in proportion among six study conditions, based on chi-square tests (p < 0.05).

2.2. Understanding of HPHCs in cigarette smoke

Understanding of HPHCs in cigarette smoke increased significantly pre- to post-exposure for all six formats (See Table 2). Mean pre-exposure scores on the 0–5 scale ranged from 1.73 (Youth, Format 3) to 1.95 (Adult, Format 5). Mean post-exposure scores ranged from 4.31 (Adult, Format 1) to 4.62 (Youth, Formats 4 and 5). Difference scores ranged from 2.43 (Adult, Format 6) to 2.79 (Youth, Formats 4 and 5). Supplemental Table 2 compares adult and youth difference scores.

Table 2.

Mean Understanding of HPHCs in Cigarette Smoke Pre- and Post-Format Exposure, by Age Group (N = 4227 total participants; N = 2903 adults, N = 1324 youth).

Age group Pre-exposure Post-exposure Difference (post – Pre)
Format Mean 95% CI Mean 95% CI Mean 95% CI p-value
1 Bar Overall 1.81 1.68, 1.95 4.39 4.30, 4.49 2.58 2.42, 2.74 <0.001
Adult 1.79 1.63, 1.96 4.31 4.20, 4.42 2.52 2.33, 2.43 <0.001
Youth 1.85 1.61, 2.10 4.57 4.41, 4.73 2.71 2.43, 2.99 <0.001
2 Spaghetti Overall 1.87 1.74, 2.01 4.50 4.42, 4.59 2.63 2.47, 2.79 <0.001
Adult 1.91 1.75, 2.08 4.49 4.39, 4.59 2.58 2.39, 2.77 <0.001
Youth 1.79 1.54, 2.04 4.53 4.37, 4.68 2.74 2.46, 3.02 <0.001
3 Smoke Overall 1.87 1.74, 2.01 4.46 4.38, 4.54 2.59 2.44, 2.75 <0.001
Adult 1.92 1.76, 2.08 4.43 4.34, 4.53 2.51 2.33, 2.69 <0.001
Youth 1.73 1.51, 2.00 4.53 4.39, 4.67 2.78 2.50, 3.05 <0.001
4 Table Overall 1.87 1.73, 2.01 4.46 4.38, 4.55 2.60 2.44, 2.75 <0.001
Adult 1.91 1.74, 2.07 4.38 4.28, 4.49 2.47 2.28, 2.67 <0.001
Youth 1.82 1.58, 2.07 4.62 4.47, 4.76 2.79 2.52, 3.06 <0.001
5 Infographic Overall 1.91 1.77, 2.04 4.50 4.42, 4.58 2.59 2.44, 2.75 <0.001
Adult 1.95 1.78, 2.11 4.45 4.35, 4.55 2.50 2.32, 2.69 <0.001
Youth 1.82 1.58, 2.07 4.62 4.47, 4.76 2.79 2.52, 3.06 <0.001
6 Wildcard Overall 1.87 1.73, 2.00 4.39 4.30, 4.48 2.52 2.36, 2.67 <0.001
Adult 1.91 1.75, 2.08 4.34 4.24, 4.45 2.43 2.24, 2.62 <0.001
Youth 1.77 1.52, 2.01 4.48 4.32, 4.64 2.72 2.44, 2.99 <0.001

Notes: Assessed using a summative scale from 0 to 5; CI = confidence interval.

2.3. Understanding of the health effects of cigarette smoking

Understanding of health effects of cigarette smoking increased significantly pre- to post- exposure for all six formats (see Table 3). Mean pre-exposure scores ranged on the 0–7 scale from 4.96 (Adult, Format 1) to 5.55 (Youth, Format 3). Mean post-exposure scores ranged from 5.95 (Adult, Format 4) to 6.65 (Youth, Format 3). Difference scores ranged from 0.79 (Adult, Format 4) to 1.28 (Youth, Format 6). Supplemental Table 4 compares youth and adult difference scores.

Table 3.

Mean Understanding of Health Effects of Cigarette Smoking Pre- and Post-Format Exposure, by Age Group (N = 4228 total participants; N = 2904 adults, N = 1324 youth).

Format Pre-exposure Post-exposure Difference (post – Pre) p-value
Age group Mean 95% CI Mean 95% CI Mean 95% CI
1 Bar Overall 5.11 4.96, 5.25 6.23 6.12, 6.35 1.12 0.99, 1.25 <0.001
Adult 4.96 4.78, 5.13 6.07 5.93, 6.20 1.11 0.95, 1.27 <0.001
Youth 5.44 5.18, 5.69 6.59 6.39, 6.79 1.15 0.92, 1.39 <0.001
2 Spaghetti Overall 5.20 5.06, 5.34 6.21 6.10, 6.33 1.01 0.89, 1.14 <0.001
Adult 5.04 4.88, 5.21 6.09 5.95, 6.23 1.05 0.90, 1.20 <0.001
Youth 5.55 5.30, 5.80 6.49 6.28, 6.70 0.94 0.71, 1.16 <0.001
3 Smoke Overall 5.24 5.11, 5.37 6.37 6.27, 6.47 1.13 1.01, 1.24 <0.001
Adult 5.16 5.00, 5.32 6.24 6.12, 6.36 1.09 0.94, 1.23 <0.001
Youth 5.43 5.19, 5.67 6.65 6.45, 6.83 1.22 1.00, 1.43 <0.001
4 Table Overall 5.28 5.14, 5.41 6.10 5.98, 6.22 0.82 0.71, 0.93 <0.001
Adult 5.15 4.99, 5.31 5.95 5.80, 6.09 0.79 0.65, 0.93 <0.001
Youth 5.53 5.30, 5.77 6.41 6.20, 6.62 0.87 0.68, 1.07 <0.001
5 Infographic Overall 5.32 5.18, 5.45 6.20 6.08, 6.32 0.88 0.76, 1.00 <0.001
Adult 5.24 5.08, 5.40 6.11 5.97, 6.25 0.87 0.72, 1.01 <0.001
Youth 5.49 5.25, 5.73 6.40 6.19, 6.61 0.91 0.69, 1.13 <0.001
6 Wildcard Overall 5.20 5.06, 5.33 6.39 6.29, 6.49 1.19 1.07, 1.32 <0.001
Adult 5.16 5.00, 5.32 6.32 6.19, 6.44 1.16 1.01, 1.31 <0.001
Youth 5.28 5.04, 5.52 6.56 6.37, 6.74 1.28 1.06, 1.50 <0.001

Notes: Assessed using a summative scale with a range of 0–7; CI = confidence interval.

2.4. Misleadingness

2.4.1. Belief that HPHC quantity substantially affects risk

Across formats and age groups, >50% of participants endorsed most of the five misleading beliefs that HPHC quantity in cigarettes substantially affects risk (Table 4).

Table 4.

Endorsement of Beliefs Indicative of Being Misled by Format, by Age Group (N = 4228 for items asked of all participants; N = 2904 adults, N = 1324 youth. N = 2930 for items asked of current cigarette users only; N = 2385 adults, N = 545 youth).

Item Age group % endorsement of misleading beliefs by format
1 bar 2 spaghetti 3 smoke 4 table 5 infographic 6 wildcard
Beliefs that HPHC quantity substantially affects risk
If a person who smokes cigarettes can’t quit, they should switch to a brand with fewer chemicals. Overall 73.5 69.6 69.0 71.6 71.1 70.6
Adult 71.9 68.0 71.2 73.4 71.6 68.9
Youth 76.9 73.4 64.2 68.1 69.9 74.4
It’s much safer to smoke cigarettes with fewer chemicals. Overall 55.3 53.9 54.3 54.2 56.7 56.1
Adult 55.0 53.6 56.9 55.0 58.2 54.6
Youth 56.1 54.6 48.4 52.6 53.4 59.4
A cigarette is much safer to smoke if it has less arsenic than other cigarettes. Overall 51.6 51.3 52.0 50.1 52.3 52.3
Adult 52.9 53.4 54.0 52.4 53.9 52.4
Youth 48.9 46.8 47.4 45.3 48.9 52.1
A cigarette is much safer to smoke if it has less crotonaldehyde than other cigarettes. Overall 50.8 51.1 49.0 48.1 51.6 51.0
Adult 49.4 51.1 50.5 48.2 53.5 49.9
Youth 53.9 50.9 45.6 47.8 47.5 53.4
A cigarette is much safer to smoke if it has less 4-aminobiphenyl than other cigarettes. Overall 52.3 47.8 46.2 48.1 48.8 48.0
Adult 52.1 48.1 47.9 47.4 49.4 48.3
Youth 52.9 47.3 42.3 49.6 47.5 47.5
Beliefs that brands vary in risk
Some cigarette brands are much more harmful to smoke than others. Overall 70.9 67.8 67.8 68.1 71.6 68.3
Adult 69.6 65.7 66.9 66.6 70.0 66.8
Youth 73.8 72.5 69.8 71.1 75.3 71.7
If a website had information like this for all cigarette brands, I would use it to see which cigarettes are safer than others. Overall 66.2 65.5 67.6 66.0 66.0 66.9
Adult 64.9 64.7 67.7 64.9 67.9 65.2
Youth 69.2 67.4 67.4 68.1 61.6 70.8
Evidence of making comparisons with incomplete data
My brand of cigarettes is probably safer than Durham.a Overall 47.6 45.9 48.7 50.5 49.0 47.7
Adult 45.5 43.5 47.6 50.9 46.5 46.6
Youth 55.8 56.7 53.6 48.9 60.2 52.8
My brand of cigarettes has fewer chemicals than Durham.a Overall 44.8 46.3 50.3 49.5 46.3 48.8
Adult 42.5 41.7 48.4 49.1 44.3 48.1
Youth 53.9 66.7 59.5 51.1 55.7 51.7
Perceptions that smoking is less dangerous
Reading this information about cigarettes makes me less likely to quit smoking.a Overall 40.7 43.6 44.1 44.5 45.5 41.7
Adult 39.3 41.7 43.6 43.8 43.8 40.7
Youth 46.2 52.2 46.4 47.7 53.4 46.2
After viewing this information about cigarettes, I now feel that smoking is less dangerous. Overall 29.2 28.9 30.8 31.5 32.3 33.2
Adult 32.0 30.2 33.1 34.0 34.2 35.1
Youth 23.1 26.2 25.6 26.3 28.3 29.2
How harmful are Durham cigarettes (the cigarettes described)? Overall 22.6 20.6 23.3 22.4 23.0 22.7
Adult 26.2 22.2 26.6 24.7 24.5 27.0
Youth 14.5 17.0 15.8 17.7 19.6 13.2
It’s safer to smoke Durham cigarettes than most other cigarettes. Overall 31.6 28.4 33.0 32.6 33.5 32.5
Adult 32.9 28.3 34.2 33.2 33.5 33.6
Youth 29.0 28.4 30.2 31.5 33.3 30.1
Durham cigarettes have fewer chemicals than other cigarettes. Overall 40.1 33.5 37.5 36.6 38.7 35.7
Adult 32.9 28.3 34.2 33.2 33.5 33.6
Youth 29.0 28.4 30.2 31.5 33.3 30.1

Note: Endorsement indicated by responding “Strongly Agree” or “Agree” on a 5-point scale for all belief items except “How harmful are Durham cigarettes (the cigarettes described)?”, for which endorsement was indicated by responding “Not at all harmful” or “A little harmful” on a 4-point scale.

a

Asked of current cigarette users only.

2.4.2. Belief that brands vary in risk

Most participants endorsed misleading beliefs that brands vary in risk after viewing HPHC information (Table 4).

2.4.3. Making comparisons with incomplete data

Approximately half of current cigarette users endorsed misleading beliefs indicative of making comparisons with incomplete HPHC information (Table 4).

2.4.4. Perception that smoking is less dangerous

For most items, fewer than half of participants perceived that smoking cigarettes is less dangerous after viewing HPHC information (Table 4).

2.4.5. Likelihood of switching

Among current cigarette users who viewed formats 1, 3, 5, or 6, there were significant increases from pre- to post- exposure in the proportion of those who reported that they would switch brands if they learned that their cigarettes have a lot more of a dangerous HPHC than other cigarettes (Table 5). There were no significant differences from pre-exposure to post-exposure for formats 2 and 4. The proportion of youth misled only significantly increased for those who viewed format 1 whereas the proportion of adults misled significantly increased for those who viewed formats 1, 3, 5, or 6.

Table 5.

Endorsement of Belief Indicating Switching due to HPHC Information Pre- and Post-Format Exposure (N = 2930 total participants; N = 2385 adults, N = 545 youth).

Age group Pre-exposure Post-exposure Difference (post – Pre)
Format % 95% CI % 95% CI % 95% CI p-value
1 Bar Overall 71.0 67.1, 75.0 77.7 74.1, 81.3 6.6 3.1, 10.2 <0.001
Youth 76.9 68.8, 85.0 87.5 81.1, 93.9 10.6 2.8, 18.3 0.008
Adult 69.5 65.1, 74.0 75.2 71.0, 79.4 5.7 1.7, 9.6 0.006
2 Spaghetti Overall 74.1 70.3, 78.0 75.8 72.0, 79.5 1.6 −1.7, 5.0 0.35
Youth 86.7 79.6, 93.7 90.0 83.8, 96.2 3.3 −1.5, 8.2 0.18
Adult 71.4 67.0, 75.8 72.6 68.2, 76.9 1.2 −2.7, 5.2 0.54
3 Smoke Overall 72.2 68.2, 76.1 76.1 72.3, 79.9 3.9 0.1, 7.7 0.04
Youth 81.0 72.6, 89.3 83.3 75.4, 91.3 2.4 −7.5, 12.3 0.64
Adult 70.3 65.8, 74.8 74.6 70.3, 78.8 4.2 0.1, 8.4 0.04
4 Table Overall 76.0 72.1, 79.9 79.2 75.6, 82.9 3.2 −0.3, 6.7 0.07
Youth 85.2 77.8, 92.6 89.8 83.4, 96.1 4.5 −2.5, 11.6 0.21
Adult 73.9 69.5, 78.3 76.8 72.5, 81.0 2.9 −1.1, 6.9 0.15
5 Infographic Overall 70.0 65.9, 74.1 74.9 71.1, 78.7 4.9 1.1, 8.7 0.01
Youth 83.0 75.1, 90.8 89.8 83.4, 96.1 6.8 −0.2, 13.9 0.06
Adult 67.2 62.6, 71.8 71.6 67.2, 76.0 4.5 0.2, 8.8 0.04
6 Wildcard Overall 71.0 66.9, 75.0 76.6 72.8, 80.3 5.6 2.1, 9.1 0.002
Youth 82.4 74.6, 90.2 86.8 79.9, 93.8 4.4 −0.9, 9.7 0.10
Adult 68.3 63.7, 72.9 74.2 69.8, 78.5 5.9 1.8, 10.0 0.005

Notes: CI = confidence interval.

3. Discussion

Public understanding of HPHCs in tobacco products and cigarette smoke is low (Brewer et al., 2016; Jeong et al., 2020; Morgan et al., 2017; Hall et al., 2014; Moracco et al., 2016; Boynton et al., 2016), but, in general, people are interested in learning about HPHCs (Wiseman et al., 2016; Morgan et al., 2017; Moracco et al., 2016; Boynton et al., 2016). Furthermore, the Tobacco Control Act requires that FDA publish a list of HPHCs in a way that is “understandable and not misleading to a layperson.” To address challenges in communicating HPHC information, we used previous research results to design six formats to communicate HPHC information, displayed them to participants, and tested understanding of HPHCs and health effects of smoking after viewing. We also tested whether the information presented in the formats was misleading.

Consistent with previous research (Lazard et al., 2020; Byron et al., 2018; Loken et al., 2021), participants’ understanding of HPHCs in cigarette smoke and the health effects of smoking increased after viewing HPHC information across all formats. All formats provided HPHC information that increased participant understanding and may, therefore, be useful models for providing people with information about HPHCs in tobacco products.

While all formats increased understanding, participants endorsed misleading beliefs after viewing the formats, which is also consistent with previous research. Beliefs that cigarette brands vary in risk and that variations in levels of individual chemicals in cigarettes substantially affects risk were among the most endorsed misleading beliefs, with 67.8–71.6% endorsing the statement that “some cigarette brands are much more harmful to smoke than others” and 69.0–73.5% endorsing the statement that “if a person who smokes cigarettes can’t quit, they should switch to a brand with fewer chemicals.” This finding is consistent with research demonstrating that people mistakenly believe they are at lower risk of harm from a product that contains fewer overall constituents or lower amounts of specific constituents (Lazard et al., 2020; Morgan et al., 2017; Byron et al., 2018) and are susceptible to brand switching in response to HPHC information (U.S. Department of Health and Human Services, 2010; Food and Drug Administration, n.d.; Food and Drug Administration, 2015). People expect that information provided to them is intended to be useful. Participants may, therefore, have assumed that brand and subbrand information about HPHC quantities was provided because it is important and relevant to their behavior (Berman et al., 2017). This may in part explain why participants indicated that they would switch brands if they learned that their cigarettes have higher amounts of a dangerous HPHC than other cigarettes. Displaying HPHC information by product category (e.g., cigarettes, ENDS, smokeless tobacco) rather than by brand may minimize potential misleadingness because individuals would not be able to make comparisons across various brands within a product category. Such displays could also educate consumers that many of the harms of smoking come from the combustion of tobacco and its inhalation, not from chemical additives (King et al., 2021).

Message features (e.g., providing familiar or unfamiliar HPHC names; providing health effect information as text only or text with icons) may influence whether HPHC information is understandable and not misleading to a lay person. Recognizing the importance of message features, we took care in designing the formats; however, our results still indicate that participants were misled. Presenting exact HPHC amounts may encourage participants to make incorrect risk comparisons. This may be due in part to challenges with health numeracy, defined as the ability to understand medical data (Centers for Disease Control and Prevention, 2021). Researchers have examined providing HPHC information with fewer numeric quantities, instead communicating overall harm or communicating information on only a few HPHCs. For example, Borgida et al. showed cigarette users and nonusers a graphic ordering smokeless tobacco brands on a gradient by toxicity and nicotine content (Borgida et al., 2015). Goldstein et al. showed adult cigarette users messages that provided information about one HPHC in cigarette smoke, its health effect, and a photo image of an individual displaying the health effect (Goldstein et al., 2021). The use of graphic elements in communicating HPHC information is also challenging. Including visual risk indicators elicits higher perceptions of usable information among viewers (Lazard et al., 2020) but supplementing quantitative information with visual features such as icons and graphic elements results in less understanding than providing text-only information (Pepper et al., 2017b; Byron et al., 2018).

Study results should be interpreted with caution considering several limitations. The sample was a non-representative convenience sample and included only individuals with access to laptop or desktop computers; thus, results cannot be generalized to the entire U.S. population. It is unclear whether participants held misleading beliefs prior to participating in the study or whether the HPHC information increased misunderstanding. Only the item related to brand switching measured pre- and post- HPHC information exposure. Future research may test misleading beliefs before and after exposure to HPHC information to assess changes in response to study stimuli. Exposure to HPHC information did not occur under real-world circumstances. In the real world, individuals would likely have to seek out HPHC information. They might pay less attention to the information because they are not required to view it for a minimum of 30 s as they were in this study, or they might pay more attention because they are seeking out the information by choice. Additionally, because the Tobacco Control Act requires HPHC information to be presented by brand and subbrand, individuals in the real world could compare across products or only look at their preferred brand, rather than seeing a single hypothetical brand as in this study. Future research may examine these possibilities.

In summary, this study examined whether viewing a format presenting HPHC information increased understanding of HPHCs in cigarette smoke and the health effects of smoking among youth and adults and mitigated misleading beliefs to meet Tobacco Control Act requirements. While understanding increased across all formats, participants still endorsed misleading beliefs post-exposure and the endorsement of one misleading belief (i.e., switching to a brand with fewer HPHCs) significantly increased pre- to post-exposure for four of the six formats. Communicating HPHC information in a way that is not misleading remains a challenge.

Supplementary Material

Supplemental Material

Acknowledgments

We thank Christopher Ellison, Ruben Montes De Oca, Antonio Paredes, and Wioletta Szeszel-Fedorowicz for their assistance conducting ad-hoc analyses. We thank Megan Nguyen and Ashley Feld for their assistance with this project.

Funding

This work was supported by the Center for Tobacco Products at the U.S. Food and Drug Administration (FDA), under a contract to to RTI International (Contract No. HHSF223201110005B).

Footnotes

Authors statement

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Food and Drug Administration.

CRediT authorship contribution statement

Samantha J. Venrick: Writing – original draft, Writing – review & editing, Formal analysis. Katherine A. Margolis: Conceptualization, Writing – review & editing, Supervision. Jennifer K. Bernat: Conceptualization, Writing – review & editing, Supervision. Jessica K. Pepper: Methodology, Investigation, Project administration. James M. Nonnemaker: Methodology, Formal analysis. Matthew E. Eggers: Methodology, Formal analysis.

Declaration of Competing Interest

The authors have no conflicts of interest to report.

Appendix A. Supplementary data

Supplementary data to this article can be found online at https://doi.org/10.1016/j.ypmed.2023.107458.

Data availability

Data will be made available on request.

References

  1. Berman ML, Byron MJ, Hemmerich N, et al. , 2017. Communicating tobacco product information to the public. Food Drug. Law J 72 (3), 386–405. [PMC free article] [PubMed] [Google Scholar]
  2. Borgida E, Loken B, Williams AL, Vitriol J, Stepanov I, Hatsukami D, 2015. Assessing constituent levels in smokeless tobacco products: a new approach to engaging and educating the public. Nicotine Tob. Res 17 (11), 1354–1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boynton MH, Agans RP, Bowling JM, et al. , 2016. Understanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: a national phone survey of U.S. adults, 2014–2015. BMC Public Health 16, 516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brewer NT, Morgan JC, Baig SA, et al. , 2016. Public understanding of cigarette smoke constituents: three US surveys. Tob. Control 26 (5), 592–599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Byron MJ, Lazard AJ, Peters E, Vu H, Schmidt A, Brewer NT, 2018. Effective formats for communicating risks from cigarette smoke chemicals. Tob. Regul. Sci 4 (2), 16–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Centers for Disease Control and Prevention, 2021. Numeracy. Health Literacy Research: Research Summaries & Science Bites Web site. https://www.cdc.gov/healthliteracy/researchevaluate/numeracy.html.
  7. Food and Drug Administration, 2015. Section 904 of the Federal Food, Drug, and Cosmetic Act- submission of health information to the Secretary. https://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm261826.htm. Published.
  8. Food and Drug Administration. Harmful And Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke: Established List. http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297786.htm.
  9. Goldstein AO, Jarman KL, Kowitt SD, et al. , 2021. Effect of cigarette constituent messages with engagement text on intention to quit smoking among adults who smoke cigarettes: a randomized clinical trial. JAMA Netw. Open 4 (2), e210045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hall MG, Ribisl KM, Brewer NT, 2014. Smokers’ and nonsmokers’ beliefs about harmful tobacco constituents: implications for FDA communication efforts. Nicotine Tob. Res 16 (3), 343–350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Houts PS, Doak CC, Doak LG, Loscalzo MJ, 2006. The role of pictures in improving health communication: a review of research on attention, comprehension, recall, and adherence. Patient Educ. Couns 61 (2), 173–190. [DOI] [PubMed] [Google Scholar]
  12. Jeong M, Noar SM, Zhang D, et al. , 2020. Public understanding of cigarette smoke chemicals: longitudinal study of US adults and adolescents. Nicotine Tob. Res 22 (5), 747–755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. King B, Borland R, Morphet K, et al. , 2021. It’s all the other stuff!’ how smokers understand (and misunderstand) chemicals in cigarettes and cigarette smoke. Public Underst. Sci 30 (6). [DOI] [PubMed] [Google Scholar]
  14. Lazard AJ, Schmidt A, Vu H, et al. , 2017. Icons for health effects of cigarette smoke: a test of semiotic type. J. Behav. Med 40 (4), 641–650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lazard AJ, Byron MJ, Vu H, Peters E, Schmidt A, Brewer NT, 2019. Website designs for communicating about chemicals in cigarette smoke. Health Commun. 34 (3), 333–342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lazard AJ, Byron MJ, Peters E, Brewer NT, 2020. Communicating about chemicals in cigarette smoke: impact on knowledge and misunderstanding. Tob. Control 29 (5), 556–563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Loken B, Borgida E, Wang T, et al. , 2021. Can the public be educated about constituents in smokeless tobacco? A three-wave randomized controlled trial. Nicotine Tob. Res 23 (1), 161–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moracco KE, Morgan JC, Mendel J, et al. , 2016. “My first thought was croutons”: perceptions of cigarettes and cigarette smoke constituents among adult smokers and nonsmokers. Nicotine Tob. Res 18 (7), 1566–1574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Morgan JC, Byron MJ, Baig SA, Stepanov I, Brewer NT, 2017. How people think about the chemicals in cigarette smoke: a systematic review. J. Behav. Med 40 (4), 553–564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nicksic NE, Barnes AJ, 2019. Is susceptibility to e-cigarettes among youth associated with tobacco and other substance use behaviors one year later? Results from the PATH study. Prev. Med 121, 109–114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Noar SM, Kelley DE, Boynton MH, et al. , 2018. Identifying principles for effective messages about chemicals in cigarette smoke. Prev. Med 106, 31–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pepper JK, Byron MJ, Ribisl KM, Brewer NT, 2017a. How hearing about harmful chemicals affects smokers’ interest in dual use of cigarettes and e-cigarettes. Prev. Med 96, 144–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pepper JK, Nonnemaker JM, DeFrank JT, et al. , 2017b. Communicating about cigarette smoke constituents: a national US survey. Tob. Regul. Sci 3 (4), 388–407. [Google Scholar]
  24. Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A, 2011. Hazardous compounds in tobacco smoke. Int. J. Environ. Res. Public Health 8 (2), 613–628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tindle HA, Shiffman S, Hartman AM, Bost JE, 2009. Switching to “lighter” cigarettes and quitting smoking. Tob. Control 18 (6), 485–490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. U.S. Department of Health and Human Services, 2010. A Report of the Surgeon General: How Tobacco Smoke Causes Disease: What it Means to you. Centers for Disease Control and Prevention, Atlanta, GA. [Google Scholar]
  27. Wiseman KD, Cornacchione J, Wagoner KG, et al. , 2016. Adolescents’ and young adults’ knowledge and beliefs about constituents in novel tobacco products. Nicotine Tob. Res 18 (7), 1581–1587. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material

Data Availability Statement

Data will be made available on request.

RESOURCES